BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7307782)

  • 1. [Treatment of myasthenia gravis with immune drugs and immunological observations on 31 cases (author's transl)].
    Yu CZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):19-22. PubMed ID: 7307782
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary observation of the effect of thymosin on myasthenia gravis].
    Zhang ZX; Ren YL; Tan MX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Oct; 6(5):366-9. PubMed ID: 6241090
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immuno suppressive drugs in the treatment of myasthenia (author's transl)].
    Buscaino GA
    Riv Patol Nerv Ment; 1974 Aug; 95(4):399-410. PubMed ID: 4377801
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymosin alpha 1 in myasthenia gravis.
    Dalakas MC; Engel WK; McClure JE; Goldstein AL
    N Engl J Med; 1980 May; 302(19):1092-3. PubMed ID: 7366630
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological study in patients with myasthenia gravis before and after thymectomy (author's transl)].
    Monden Y; Masaoka A; Maeda M; Nakahara K; Oshima S; Hirose H; Matsuyama M; Tani Y; Shirakura R; Seike Y; Nakata S; Nakaoka K; Kagotani K; Nishikawa H
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Nov; 27(11):1477-84. PubMed ID: 536626
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological study in patients with myasthenia gravis (author's transl)].
    Monden Y; Masaoka A; Maeda M; Nakahara K; Oshima S; Hirose H; Matsuyama M; Tani Y; Seike Y; Nakata S; Nakaoka K; Tanioka T; Kagotani K; Nishikawa H
    Nihon Kyobu Geka Gakkai Zasshi; 1978 Nov; 26(11):1369-74. PubMed ID: 731076
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of myasthenia gravis with immunosuppressants (author's transl)].
    Yang RM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):23-5. PubMed ID: 7307783
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myasthenia gravis and thymectomy in a 2 year old girl (author's transl)].
    Bégué P; Del Bono GP; Binet JP; Lasfargues G
    Arch Fr Pediatr; 1980 Apr; 37(4):259-61. PubMed ID: 7406642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
    Ohshima F
    No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of neuroblastoma with transfer factor (author's transl)].
    Prats J; Padulles J; Español T; García Calderón P; Martínez-Mora J
    An Esp Pediatr; 1976 Nov; 9(8):41-3. PubMed ID: 1015680
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lymphocytotoxic antibodies in myasthenia gravis (author's transl)].
    Mine M; Eguchi K; Tsujihata M; Fukuda T; Takamori M
    Rinsho Shinkeigaku; 1980 Oct; 20(10):825-30. PubMed ID: 7460417
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia gravis: therapeutical-immunological correlation.
    de Assis JL; Saraiva S
    Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(6):213-6. PubMed ID: 4950682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
    Rousseau JJ; Dieudonne LG
    Acta Neurol Belg; 1980; 80(3):165-73. PubMed ID: 7457085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myasthenia gravis associated with IgA defect (author's transl)].
    Gehin P; Barroche G; Rivail J; Weber M
    Rev Otoneuroophtalmol; 1980; 52(2):163-71. PubMed ID: 7414170
    [No Abstract]   [Full Text] [Related]  

  • 15. [The jitter-phenomenon in myasthenia gravis and the influence of diazepame. An electromyographic study of single muscle fibre (author's transl)].
    Milonas I; Kountouris D; Müller E
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1981 Dec; 12(4):183-4. PubMed ID: 6800761
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical studies on a case of bronchial asthma with myasthenia gravis (author's transl)].
    Kimura I; Tanizaki Y; Nakata Y; Takahashi K; Hosokawa M; Ono H; Ishibashi K; Goda Y; Nakamura Y; Sasaki Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Feb; 16(2):98-102. PubMed ID: 651033
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 18. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical and immunological study of a myasthenia gravis patient treated with infliximab.
    Kakoulidou M; Bjelak S; Pirskanen R; Lefvert AK
    Acta Neurol Scand; 2007 Apr; 115(4):279-83. PubMed ID: 17376128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.